Primer Name | Sequences (5’>3’) | PCR Product |
---|---|---|
EGFR-M Forward | TGT TTT TTT CGC GTT TCG GTT CGC GC | 150 bp |
EGFR-M Reverse | CGT CTA AAC GAC GAC GAC CGC CG | |
EGFR-UM Forward | TGT TTT GTT TTT TTG TGT TTT GGT TTG TGT | |
EGFR-UM Reverse | CAT CCA ATC TAA ACA ACA ACA ACC ACC A | 150 bp |
MS-PCR | ||
---|---|---|
Methylated | Unmethylated | Methylation Profile |
[–] | [+] | unmethylated |
[+] | [–] | methylated |
[+] | [+] | methylated |
[–] | [–] | excluded from study |
Control Group | MS-PCR | Methylation Profile | Patient Group | MS-PCR | Methylation Profile | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Ct | M | Ct | UM | Ct | M | Ct | UM | ||||
Positive Controla | 27.33 | [+] | 40.00 | [–] | M | Positive Controla | 27.33 | [+] | 40.00 | [–] | M |
C-1 | 34.37 | [+] | 32.28 | [+] | M | P-1 | 33.72 | [+] | 31.41 | [+] | M |
C-2 | 32.86 | [+] | 30.67 | [+] | M | P-2 | 29.87 | [+] | 29.77 | [+] | M |
C-3 | 31.43 | [+] | 28.88 | [+] | M | P-3 | 33.21 | [+] | 31.95 | [+] | M |
C-4 | 32.92 | [+] | 29.35 | [+] | M | P-4 | 31.68 | [+] | 29.50 | [+] | M |
C-5 | 31.82 | [+] | 29.74 | [+] | M | P-5 | 32.60 | [+] | 29.89 | [+] | M |
C-6 | 31.93 | [+] | 28.99 | [+] | M | P-6 | 30.82 | [+] | 29.36 | [+] | M |
C-7 | 31.91 | [+] | 28.57 | [+] | M | P-7 | 32.47 | [+] | 29.00 | [+] | M |
C-8 | 35.95 | [–] | 32.27 | [+] | UM | P-8 | 31.66 | [+] | 28.34 | [+] | M |
C-9 | 31.25 | [+] | 29.97 | [+] | M | P-9 | 30.84 | [+] | 29.53 | [+] | M |
C-10 | 29.84 | [+] | 27.52 | [+] | M | P-10 | 32.65 | [+] | 29.36 | [+] | M |
C-11 | 32.69 | [+] | 30.40 | [+] | M | P-11 | 35.32 | [–] | 33.99 | [+] | UM |
C-12 | 33.58 | [+] | 33.50 | [+] | M | P-12 | 36.56 | [–] | 34.23 | [+] | UM |
C-13 | 33.67 | [+] | 29.72 | [+] | M | P-13 | 32.74 | [+] | 30.43 | [+] | M |
C-14 | 34.55 | [+] | 30.58 | [+] | M | P-14 | 34.57 | [+] | 32.49 | [+] | M |
C-15 | 33.94 | [+] | 30.88 | [+] | M | P-15 | 33.73 | [+] | 30.99 | [+] | M |
C-16 | 33.88 | [+] | 29.60 | [+] | M | P-16 | 35.42 | [–] | 33.56 | [+] | UM |
C-17 | 34.66 | [+] | 32.72 | [+] | M | P-17 | 35.56 | [–] | 31.58 | [+] | UM |
C-18 | 32.31 | [+] | 29.43 | [+] | M | P-18 | 34.46 | [+] | 31.25 | [+] | M |
C-19 | 33.84 | [+] | 30.86 | [+] | M | P-19 | 36.38 | [–] | 33.45 | [+] | UM |
C-20 | 33.76 | [+] | 30.72 | [+] | M | P-20 | 35.12 | [–] | 32.46 | [+] | UM |
C-21 | 33.30 | [+] | 29.73 | [+] | M | P-21 | 35.98 | [–] | 33.72 | [+] | UM |
C-22 | 34.56 | [+] | 29.86 | [+] | M | P-22 | 33.67 | [+] | 31.98 | [+] | M |
C-23 | 33.40 | [+] | 30.30 | [+] | M | P-23 | 34.28 | [+] | 31.94 | [+] | M |
C-24 | 33.97 | [+] | 31.45 | [+] | M | P-24 | 34.77 | [+] | 31.80 | [+] | M |
C-25 | 33.30 | [+] | 30.37 | [+] | M | P-25 | 33.33 | [+] | 31.58 | [+] | M |
C-26 | 32.88 | [+] | 30.47 | [+] | M | P-26 | 32.55 | [+] | 30.69 | [+] | M |
C-27 | 32.35 | [+] | 31.44 | [+] | M | P-27 | 33.65 | [+] | 31.66 | [+] | M |
C-28 | 34.17 | [+] | 31.74 | [+] | M | P-28 | 32.99 | [+] | 29.57 | [+] | M |
C-29 | 33.24 | [+] | 30.55 | [+] | M | P-29 | 33.22 | [+] | 28.42 | [+] | M |
C-30 | 32.74 | [+] | 28.52 | [+] | M | P-30 | 35.51 | [–] | 28.80 | [+] | UM |
C-31 | 33.21 | [+] | 27.67 | [+] | M | P-31 | 33.48 | [+] | 28.53 | [+] | M |
C-32 | 35.24 | [+] | 30.34 | [+] | UM | P-32 | 34.27 | [+] | 29.92 | [+] | M |
C-33 | 32.86 | [–] | 27.26 | [+] | M | P-33 | 32.63 | [+] | 27.98 | [+] | M |
C-34 | 32.42 | [+] | 28.35 | [+] | M | P-34 | 32.88 | [+] | 27.72 | [+] | M |
C-35 | 32.29 | [+] | 28.39 | [+] | M | P-35 | 33.68 | [+] | 29.86 | [+] | M |
C-36 | 33.80 | [+] | 28.59 | [+] | M | P-36 | 33.67 | [+] | 28.82 | [+] | M |
C-37 | 34.38 | [+] | 27.65 | [+] | M | P-37 | 34.92 | [+] | 30.58 | [+] | M |
C-38 | 33.61 | [+] | 27.66 | [+] | M | P-38 | 33.78 | [+] | 29.73 | [+] | M |
C-39 | 33.81 | [+] | 28.85 | [+] | M | P-39 | 35.75 | [–] | 28.32 | [+] | UM |
C-40 | 32.49 | [+] | 28.40 | [+] | M | P-40 | 34.72 | [+] | 29.49 | [+] | M |
C-41 | 33.84 | [+] | 29.66 | [+] | M | P-41 | 32.83 | [+] | 28.61 | [+] | M |
C-42 | 34.29 | [+] | 28.94 | [+] | M | P-42 | 35.31 | [–] | 30.58 | [+] | UM |
C-43 | 33.97 | [+] | 29.58 | [+] | M | P-43 | 32.45 | [+] | 27.63 | [+] | M |
C-44 | 35.82 | [–] | 30.24 | [+] | UM | P-44 | 33.76 | [+] | 29.67 | [+] | M |
C-45 | 35.75 | [–] | 30.19 | [+] | UM | P-45 | 32.99 | [+] | 28.25 | [+] | M |
C-46 | 35.90 | [–] | 30.22 | [+] | UM | P-46 | 33.71 | [+] | 28.53 | [+] | M |
C-47 | 33.00 | [+] | 28.23 | [+] | M | P-47 | 32.89 | [+] | 28.45 | [+] | M |
C-48 | 33.59 | [+] | 29.34 | [+] | M |
Parameters | EGFR Methylation Profile | |||
---|---|---|---|---|
Methylated | Unmethylated | |||
Age: | 4 | 3 | 1 | 0.908a |
Gender: | 41 | 33 | 8 | 0.494a |
Tumor stage: | 20 | 14 | 6 | 0.184a |
Sample | EGFR Promoter Methylation Profile (%) | ||
---|---|---|---|
Methylated | Unmethylated | ||
Control | 43 (90.0); | 5 (10.0) | 0.121a |
Patient | 37 (79.0) | 10 (21.0) |
Control Group ( | Patient Group ( | |
---|---|---|
Gender | males: 36 (75.00); females: 12 (25.00) | males: 41 (87.00); females: 6 (13.00) |
Median age | 58 | 59 |
Tumor type | – | Larynx: 31 (65.96) |
Tumor stage | – | T1: 10 (21.27) |